logo
logo

Sixfold Bioscience Completes $10.5M Usd (£7.8M Gbp) Seed Financing

Dec 02, 2021•almost 4 years ago

Amount Raised

$10.5 Million

Round Type

seed

BostonOther

Description

Sixfold Bioscience (Sixfold), a company harnessing computation and advanced chemistry to design RNA therapeutic delivery systems, today announced it has raised a total of $10.5 million USD (£7.8 million GBP) in its seed funding round. The funding will support the continued development of the Company’s Mergo® RNA therapeutics delivery platform.

Company Information

Company

hC Bioscience

Location

Boston, Massachusetts, United States

About

hC Bioscience is dedicated to improving the lives of patients with the development of first-in-class tRNA-based therapeutics targeting protein dysfunction. hC’s innovations in precision protein editing therapies target genetically defined diseases. A single tRNA therapy has the potential to treat many diseases, regardless of the gene or location of the mutation.

Related People

0 contacts

No contacts found in Executives department

Try selecting a different department above

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech